Investor insights
Sectors invested in
Cancer therapies1
Biotechnology1
Gene editing1
Cell therapies1
Crispr/Cas91
Plasmid1
mRNA1
High throughput technology1
Gene therapies1
Viral vectors1
Medical devices1
Bioprocessing1
Microfluidics1
Biotech1
Cell engineering1
Health Care1
Enterprise Software1
Developer Tools1
Bioinformatics1
Software1
Funding rounds participated in
$21M sweet spot round size
Most of their 2 investments are in rounds between $20M and $22M
Investor type
Venture Capital
Basic info
Industry
venture capital and private equity principals
Sectors
Life Science Venture Capital
TechBio
HealthTech
Date founded
2021
Investments made
C
CellFE - Cell Fluidics Engineering raised $22M on September 27, 2023
Investors: GreatPoint Ventures, Khosla Ventures, Embark Ventures, M Ventures, Elm Street Ventures, Cota Capital and Riverine Ventures
G
Genomenon, Inc raised $20M on March 8, 2022
Investors: Michigan Rise, IrishAngels, Red Cedar Ventures, BroadOak Capital Partners, Spring Mountain Capital, -, Green Park & Golf Ventures, Michigan Angel Fund and Riverine Ventures